Journal of the American Geriatrics Society · 2008 · 200 citations · 33 references
PharmacyGeriatric PharmacyPharmaceutical PolicyMedication Safety PolicyPatient SafetyPharmaceutical ComplianceMedication ManagementMedication ReviewMedication SafetyMedication UseMedication-related Injury PreventionRational PrescribingClinical Care QualityDrug DiscontinuationMedication Prescribing SafetyMedication Process ImprovementMedication Use PolicyMedication Use Process EvaluationMedication-related Harm ReductionPrescribing Practices
Adverse drug reactions injure or kill thousands of Americans annually, many preventable, making medication‑use safety a public health priority; current efforts focus on prescribing, with little emphasis on discontinuation, so a formalized approach to rationally discontinue medications is needed to improve safety and quality of care. This article proposes a conceptual framework for revising the prescribing stage of the medication‑use process to include discontinuing medications. The framework revises the prescribing stage by incorporating a structured discontinuation process. The framework has substantial practice and research implications, especially for the clinical care of older persons who are particularly susceptible to medication adverse effects.
Thousands of Americans are injured or die each year from adverse drug reactions, many of which are preventable. The burden of harm conveyed by the use of medications is a significant public health problem, and therefore, improving the medication-use process is a priority. Recent and ongoing efforts to improve the medication-use process have focused primarily on improving medication prescribing, and not much emphasis has been put on improving medication discontinuation. A formalized approach for rationally discontinuing medications is a necessary antecedent to improving medication safety and improving the nation's quality of care. This article proposes a conceptual framework for revising the prescribing stage of the medication-use process to include discontinuing medications. This framework has substantial practice and research implications, especially for the clinical care of older persons, who are particularly susceptible to the adverse effects of medications.
33
Incidence of Adverse Drug Events and Potential Adverse Drug Events
David W. Bates · JAMA · 1995 · 2.1K citations
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Jerry H. Gurwitz, Terry S. Field, Leslie R. Harrold et al. · JAMA · 2003 · 1.7K citations
Pharmacy, Gynecology, Obstetrics +11
Effects of Continuing or Stopping Alendronate After 5 Years of Treatment
Dennis M. Black, Ann V. Schwartz, Kristine E. Ensrud et al. · JAMA · 2006 · 1.4K citations